Application 211330

Type: ANDA
Sponsor: VISTAPHARM

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	GABAPENTIN	GABAPENTIN	SOLUTION;ORAL	250MG/5ML	No	No

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A211330-001	GABAPENTIN	GABAPENTIN	250MG/5ML	SOLUTION / ORAL	AA		2019-12-03

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
A211330-001	AA

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A211330-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL	AA	2019-12-03	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A211330-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL	AA	2019-12-03	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A211330-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL	AA	2019-12-03	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A211330-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL		2019-12-03	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A211330-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL		2019-12-03	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A211330-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL		2019-12-03	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A211330-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL		2019-12-03	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A211330-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL		2019-12-03	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A211330-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL		2019-12-03	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A211330-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL		2019-12-03	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A211330-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL		2019-12-03	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A211330-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL		2019-12-03	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A211330-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL		2019-12-03	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A211330-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL		2019-12-03	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A211330-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL		2019-12-03	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A211330-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL		2019-12-03	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A211330-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL		2019-12-03	`4b0b4de00fa7…`
2022-03-09 01:35 UTC	2022-03	A211330-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL		2019-12-03	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A211330-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL		2019-12-03	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A211330-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL		2019-12-03	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A211330-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL		2019-12-03	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A211330-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL		2019-12-03	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A211330-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL		2019-12-03	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A211330-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL	AA	2019-12-03	`3f01610625f2…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A211330-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL		2019-12-03	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A211330-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL		2019-12-03	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A211330-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL		2019-12-03	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A211330-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL		2019-12-03	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A211330-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL		2019-12-03	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A211330-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL		2019-12-03	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A211330-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL		2019-12-03	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A211330-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL		2019-12-03	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A211330-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL		2019-12-03	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A211330-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL		2019-12-03	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A211330-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL		2019-12-03	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A211330-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL		2019-12-03	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A211330-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL		2019-12-03	`cb3db0bc1861…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A211330-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL	AA	2019-12-03	`a50c72e98297…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A211330-001	AA	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A211330-001	AA	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A211330-001	AA	1	`6a471c1ec25d…`
2019-12-14 00:12 UTC	2019-12	A211330-001	AA	1	`3f01610625f2…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A211330-001	AA	1	`a50c72e98297…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Gabapentin	GABAPENTIN	American Health Packaging	e00f5048-1a06-44f4-b244-aa2755f4be22	2026-03-02	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 211330 application number: ANDA211330
Gabapentin	GABAPENTIN	PAI Holdings, LLC dba PAI Pharma	6d3fd1f9-c831-4262-af10-291838a53541	2025-05-31	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 211330 application number: ANDA211330